🚀 VC round data is live in beta, check it out!
Coltene Valuation Multiples
Discover revenue and EBITDA valuation multiples for Coltene and similar public comparables like Cerus, IVF hartmann, CellaVision, OrthoPediatrics and more.
Coltene Overview
About Coltene
Coltene Holding AG is a Switzerland based company engaged in developing, manufacturing, and selling a range of disposables and tools for dentists and dental laboratories. The company divides its comprehensive product range into categories such as Infection Control, Dental Preservation, and Efficient Treatment categories. It offers products like aspirator tips, high-performance rotary instruments, dental dams and root canal instruments among others. The firm has its geographic presence in EMEA, North America, Latin America, and Asia/Oceania regions.
Founded
2005
HQ
Employees
1.2K
Website
Financials (LTM)
EV
$440M
Coltene Financials
Coltene reported last 12-month revenue of $307M and EBITDA of $37M.
In the same LTM period, Coltene generated $37M in EBITDA and $21M in net income.
Revenue (LTM)
Coltene P&L
In the most recent fiscal year, Coltene reported revenue of $308M and EBITDA of $36M.
Coltene expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $307M | XXX | $308M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $191M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 62% | XXX | XXX | XXX |
| EBITDA | $37M | XXX | $36M | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $21M | XXX | $19M | XXX | XXX | XXX |
| Net Margin | 7% | XXX | 6% | XXX | XXX | XXX |
| Net Debt | — | — | $34M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Coltene Stock Performance
Coltene has current market cap of $406M, and enterprise value of $440M.
Market Cap Evolution
Coltene's stock price is $67.96.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $440M | $406M | 0.2% | XXX | XXX | XXX | $3.21 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialColtene Valuation Multiples
Coltene trades at 1.4x EV/Revenue multiple, and 11.9x EV/EBITDA.
EV / Revenue (LTM)
Coltene Financial Valuation Multiples
As of April 19, 2026, Coltene has market cap of $406M and EV of $440M.
Equity research analysts estimate Coltene's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Coltene has a P/E ratio of 19.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $406M | XXX | $406M | XXX | XXX | XXX |
| EV (current) | $440M | XXX | $440M | XXX | XXX | XXX |
| EV/Revenue | 1.4x | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | 11.9x | XXX | 12.2x | XXX | XXX | XXX |
| EV/EBIT | 15.6x | XXX | 16.3x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 2.3x | XXX | XXX | XXX |
| P/E | 19.8x | XXX | 21.2x | XXX | XXX | XXX |
| EV/FCF | 31.9x | XXX | 42.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Coltene Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Coltene Margins & Growth Rates
Coltene's revenue in the last 12 month declined by (0%).
Coltene's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Coltene's rule of 40 is 12% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Coltene's rule of X is 10% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Coltene Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | (0%) | XXX | (1%) | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | 8% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 12% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 10% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 10% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 53% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Coltene Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Coltene | XXX | XXX | XXX | XXX | XXX | XXX |
| Cerus | XXX | XXX | XXX | XXX | XXX | XXX |
| IVF hartmann | XXX | XXX | XXX | XXX | XXX | XXX |
| CellaVision | XXX | XXX | XXX | XXX | XXX | XXX |
| OrthoPediatrics | XXX | XXX | XXX | XXX | XXX | XXX |
| TaiDoc Technology | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Coltene M&A Activity
Coltene acquired XXX companies to date.
Last acquisition by Coltene was on XXXXXXXX, XXXXX. Coltene acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Coltene
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialColtene Investment Activity
Coltene invested in XXX companies to date.
Coltene made its latest investment on XXXXXXXX, XXXXX. Coltene invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Coltene
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Coltene
| When was Coltene founded? | Coltene was founded in 2005. |
| Where is Coltene headquartered? | Coltene is headquartered in Switzerland. |
| How many employees does Coltene have? | As of today, Coltene has over 1K employees. |
| Is Coltene publicly listed? | Yes, Coltene is a public company listed on SIX Swiss Exchange. |
| What is the stock symbol of Coltene? | Coltene trades under CLTN ticker. |
| When did Coltene go public? | Coltene went public in 2006. |
| Who are competitors of Coltene? | Coltene main competitors are Cerus, IVF hartmann, CellaVision, OrthoPediatrics. |
| What is the current market cap of Coltene? | Coltene's current market cap is $406M. |
| What is the current revenue of Coltene? | Coltene's last 12 months revenue is $307M. |
| What is the current revenue growth of Coltene? | Coltene revenue growth (NTM/LTM) is (0%). |
| What is the current EV/Revenue multiple of Coltene? | Current revenue multiple of Coltene is 1.4x. |
| Is Coltene profitable? | Yes, Coltene is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Coltene? | Coltene's last 12 months EBITDA is $37M. |
| What is Coltene's EBITDA margin? | Coltene's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of Coltene? | Current EBITDA multiple of Coltene is 11.9x. |
| What is the current FCF of Coltene? | Coltene's last 12 months FCF is $14M. |
| What is Coltene's FCF margin? | Coltene's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of Coltene? | Current FCF multiple of Coltene is 31.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.